You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immunotherapy

Showing 26 - 40 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Chemo Effect, Chemoradiation Trial in Beijing (drug, radiation, procedure)

Recruiting
  • Esophageal Cancer
  • +6 more
  • Platinum based chemotherapy
  • +6 more
  • Beijing, China
    Department of Radiation Oncology, National Cancer Center/Nationa
Mar 26, 2021

Breast Carcinoma, Colorectal Carcinoma Trial in Duarte (procedure, drug, radiation)

Not yet recruiting
  • Breast Carcinoma
  • Colorectal Carcinoma
  • Biopsy
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Nov 8, 2023

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Biliary Tract Cancer, Extrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial in Guangzhou (drug, other, procedure, radiation)

Active, not recruiting
  • Biliary Tract Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 20, 2020

QUantitative Assessment of Swallowing After Radiation (QUASAR)

Recruiting
  • Head and Neck Cancer
  • +4 more
  • Radiation Therapy
  • +3 more
  • La Jolla, California
  • +1 more
Feb 4, 2021

Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Recruiting
  • Immunotherapy
  • Lung Cancer
  • Immunotherapy
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong General Hospital, Gua
Feb 25, 2020

Metastatic Tumors Trial in Worldwide (radiation, drug, other)

Recruiting
  • Metastatic Tumors
  • Palliative Radiation
  • +5 more
  • Melbourne, Victoria, Australia
  • +13 more
Oct 13, 2022

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Immunotherapy
  • Chemotherapeutic Agent
  • San Diego, California
    Persephone Biosciences, Inc.
Feb 19, 2021

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Conroe, Texas
  • +4 more
May 3, 2022

EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,

Terminated
  • EGFR Activating Mutation
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 28, 2021

Immune Checkpoint Inhibitor Therapy- Induced Endocrinopathy

Recruiting
  • Endocrinopathy
  • Immunotherapy
  • Taipei, Taiwan
    Shyang-Rong Shih
Sep 3, 2019

Allergic Asthma Trial in East Hanover (Placebo, Omalizumab, Immunotherapy)

Completed
Has Results
  • Allergic Asthma
  • Placebo
  • +2 more
  • East Hanover, New Jersey
    Novartis
Aug 2, 2016

Triple Negative Breast Tumors Trial in Xi'an (Chemo, Immunotherapy)

Withdrawn
  • Triple Negative Breast Neoplasms
  • Xi'an, Shaanxi, China
    the First Affiliated Hospital of Xi 'an Jiaotong University
Aug 9, 2016

Clinical Utilization of Newly Approved Oncology Medications

Unknown status
  • Cancer
  • immunotherapy
  • Riyadh, Saudi Arabia
  • +1 more
May 23, 2016

Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Juvenile Myelomonocytic Leukemia Trial in Memphis (other,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • NK Cell Infusion
  • +6 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 15, 2013